ARCHIVES

Executive Committee, Board of Scientific Advisors concur.

This article is from The Cancer Letter archive.

Vol. 30 No. 01 | January 2, 2004

Download PDF Visit The Full Archive

Related Articles

Genomic Test More Accurate In Predicting Metastasis Than PSA, Tumor Stage & Grade

February 22, 2013

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

The Cancer Letter Wins Investigative Reporting Award

June 8, 2001

ASCO Hit On Two Sides; AACR Split Criticized

June 26, 1992

Sirolimus-Containing Therapy Reduces GVHD, Study Finds

January 31, 2003

NCI Picks 11 Centers For Chemical Biology Consortium

October 23, 2009